HC Wainwright & Co. Reiterates Buy on Q32 Bio, Maintains $13 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 91.0%

Neg 0% Neu 91% Pos 0%

HC Wainwright & Co. analyst Joseph Pantginis reiterates Q32 Bio (NASDAQ:QTTB) with a Buy and maintains $13 price target.